Daniel Varela, MD
Cardiovascular Disease · St George, UTNPI 1508220054
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (34.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 39.2% of the total. Reporting peaked in 2023 at $16,026 and has fallen 68.3% since, to $5,079 in 2025. Among cardiovascular disease clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $153.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Boston Scientific$8K
- Medtronic$5K
- Medical Device Business Services, Inc.$3K
- Biosense Webster, Inc.$3K
- Altathera Pharmaceuticals LLC$2K
- plus $3K from 9 others
What the payments were for
- Consulting fees$1,8755%
- Grants$13,89834%
- Travel & lodging$10,26125%
- Food & beverage$13,01032%
- Education$1,4053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 84 | $15,861 |
| Boston Scientific | 24 | $8,168 |
| Medtronic | 51 | $5,426 |
| Medical Device Business Services, Inc. | 17 | $3,215 |
| Biosense Webster, Inc. | 37 | $2,727 |
| Altathera Pharmaceuticals LLC | 2 | $2,031 |
| Biotronik Inc. | 22 | $1,125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $724 |
| Cardiva Medical, Inc. | 8 | $395 |
| Astellas Pharma US Inc | 2 | $198 |
| Atricure, Inc. | 3 | $177 |
| Sanofi-aventis U.S. LLC | 1 | $130 |
| Bayer | 1 | $121 |
| Edwards Lifesciences | 1 | $80 |
| Abiomed | 3 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,000
- Carto 3$4,440
- ENSITE PRECISION$2,519
- GENERAL - THERAPIES$2,105
- Sotalol Hydrochloride$2,031
- Micra$1,205
- AVEIR$1,203
- AURORA EV-ICD MRI SURESCAN$799
- ASSURITY$785
- ENSITE$639
- Acticor 7 VR-T DX$275
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$228
- HeartMate 3 Left Ventricular Assist Device$216
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$190
- WATCHMAN Access System$171
- LifeVest$165
- Rivacor 7 DR-T$150
- Solia$150
- Selectra$150
- AMVIA EDGE$150
How this compares
$40,449 in reported general payments places this provider in the 90th percentile of 131 cardiovascular disease providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in St George
- Jamison JonesSt George$12K
- Nicholas LaffelySt George$4K
- John RyanSalt Lake City$1.4M
- Robert FowlesSalt Lake City$611K
- Brian WhisenantMurray$416K
- Andrew BehuninDraper$192K
- Jeffrey OsbornSalt Lake City$69K
- James FangSalt Lake City$67K
- Joseph MuhlesteinMurray$65K
- Hannah RaaschSalt Lake City$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.